Global Cardiovascular and Renal Outcomes of Reduced GFR

Thomas B, Matsushita K, Abate KH, Al-Aly Z, Amlov J, Asayama K, Atkins R, Badawi A, Ballew SH, Banerjee A, Barregard L, et al. (2017)
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 28(7): 2167-2179.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Thomas, Bemadette; Matsushita, Kunihiro; Abate, Kalkidan Hassen; Al-Aly, Ziyad; Amlov, Johan; Asayama, Kei; Atkins, Robert; Badawi, Alaa; Ballew, Shoshana H.; Banerjee, Amitava; Barregard, Lars; Barrett-Connor, Elizabeth
Alle
Abstract / Bemerkung
The burden of premature death and health loss from ESRD is well described. Less is known regarding the burden of cardiovascular disease attributable to reduced GFR. We estimated the prevalence of reduced GFR categories 3, 4, and 5 (not on RRT) for 188 countries at six time points from 1990 to 2013. Relative risks of cardiovascular outcomes by three categories of reduced GFR were calculated by pooled random effects meta-analysis. Results are presented as deaths for outcomes of cardiovascular disease and ESRD and as disability-adjusted life years for outcomes of cardiovascular disease, GFR categories 3, 4, and 5, and ESRD. In 2013, reduced GFR was associated with 4% of deaths worldwide, or 2.2 million deaths (95% uncertainty interval [95% UI], 2.0 to 2.4 million). More than half of these attributable deaths were cardiovascular deaths (1.2 million; 95% UI, 1.1 to 1.4 million), whereas 0.96 million (95% UI, 0.81 to 1.0 million) were ESRD-related deaths. Compared with metabolic risk factors, reduced GFR ranked below high systolic BP, high body mass index, and high fasting plasma glucose, and similarly with high total cholesterol as a risk factor for disability-adjusted life years in both developed and developing world regions. In conclusion, by 2013, cardiovascular deaths attributed to reduced GFR outnumbered ESRD deaths throughout the world. Studies are needed to evaluate the benefit of early detection of CKD and treatment to decrease these deaths.
Erscheinungsjahr
2017
Zeitschriftentitel
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Band
28
Ausgabe
7
Seite(n)
2167-2179
ISSN
1046-6673
eISSN
1533-3450
Page URI
https://pub.uni-bielefeld.de/record/2912974

Zitieren

Thomas B, Matsushita K, Abate KH, et al. Global Cardiovascular and Renal Outcomes of Reduced GFR. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2017;28(7):2167-2179.
Thomas, B., Matsushita, K., Abate, K. H., Al-Aly, Z., Amlov, J., Asayama, K., Atkins, R., et al. (2017). Global Cardiovascular and Renal Outcomes of Reduced GFR. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 28(7), 2167-2179. doi:10.1681/ASN.2016050562
Thomas, B., Matsushita, K., Abate, K. H., Al-Aly, Z., Amlov, J., Asayama, K., Atkins, R., Badawi, A., Ballew, S. H., Banerjee, A., et al. (2017). Global Cardiovascular and Renal Outcomes of Reduced GFR. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 28, 2167-2179.
Thomas, B., et al., 2017. Global Cardiovascular and Renal Outcomes of Reduced GFR. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 28(7), p 2167-2179.
B. Thomas, et al., “Global Cardiovascular and Renal Outcomes of Reduced GFR”, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, vol. 28, 2017, pp. 2167-2179.
Thomas, B., Matsushita, K., Abate, K.H., Al-Aly, Z., Amlov, J., Asayama, K., Atkins, R., Badawi, A., Ballew, S.H., Banerjee, A., Barregard, L., Barrett-Connor, E., Basu, S., Bello, A.K., Bensenor, I., Bergstrom, J., Bikbov, B., Blosser, C., Brenner, H., Carrero, J.-J., Chadban, S., Cirillo, M., Cortinovis, M., Courville, K., Dandona, L., Dandona, R., Estep, K., Fernandes, J., Fischer, F., Fox, C., Gansevoort, R.T., Gona, P.N., Gutierrez, O.M., Hamidi, S., Hanson, S.W., Himmelfarb, J., Jassal, S.K., Jee, S.H., Jha, V., Jimenez-Corona, A., Jonas, J.B., Kengne, A.P., Khader, Y., Khang, Y.-H., Kim, Y.J., Klein, B., Klein, R., Kokubo, Y., Kolte, D., Lee, K., Levey, A.S., Li, Y., Lotufo, P., Abd El Razek, H.M., Mendoza, W., Metoki, H., Mok, Y., Muraki, I., Muntner, P.M., Noda, H., Ohkubo, T., Ortiz, A., Perico, N., Polkinghorne, K., Al-Radaddi, R., Remuzzi, G., Roth, G., Rothenbacher, D., Satoh, M., Saum, K.-U., Sawhney, M., Schoettker, B., Shankar, A., Shlipak, M., Silva, D.A.S., Toyoshima, H., Ukwaja, K., Umesawa, M., Vollset, S.E., Warnock, D.G., Werdecker, A., Yamagishi, K., Yano, Y., Yonemoto, N., Zaki, M.E.S., Naghavi, M., Forouzanfar, M.H., Murray, C.J.L., Coresh, J., Vos, T.: Global Cardiovascular and Renal Outcomes of Reduced GFR. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 28, 2167-2179 (2017).
Thomas, Bemadette, Matsushita, Kunihiro, Abate, Kalkidan Hassen, Al-Aly, Ziyad, Amlov, Johan, Asayama, Kei, Atkins, Robert, Badawi, Alaa, Ballew, Shoshana H., Banerjee, Amitava, Barregard, Lars, Barrett-Connor, Elizabeth, Basu, Sanjay, Bello, Aminu K., Bensenor, Isabela, Bergstrom, Jaclyn, Bikbov, Boris, Blosser, Christopher, Brenner, Hermann, Carrero, Juan-Jesus, Chadban, Steve, Cirillo, Massimo, Cortinovis, Monica, Courville, Karen, Dandona, Lalit, Dandona, Rakhi, Estep, Kara, Fernandes, Joao, Fischer, Florian, Fox, Caroline, Gansevoort, Ron T., Gona, Philimon N., Gutierrez, Orlando M., Hamidi, Samer, Hanson, Sarah Wulf, Himmelfarb, Jonathan, Jassal, Simerjot K., Jee, Sun Ha, Jha, Vivekanand, Jimenez-Corona, Aida, Jonas, Jost B., Kengne, Andre Pascal, Khader, Yousef, Khang, Young-Ho, Kim, Yun Jin, Klein, Barbara, Klein, Ronald, Kokubo, Yoshihiro, Kolte, Dhaval, Lee, Kristine, Levey, Andrew S., Li, Yongmei, Lotufo, Paulo, Abd El Razek, Hassan Magdy, Mendoza, Walter, Metoki, Hirohito, Mok, Yejin, Muraki, Isao, Muntner, Paul M., Noda, Hiroyuki, Ohkubo, Takayoshi, Ortiz, Alberto, Perico, Norberto, Polkinghorne, Kevan, Al-Radaddi, Rajaa, Remuzzi, Giuseppe, Roth, Gregory, Rothenbacher, Dietrich, Satoh, Michihiro, Saum, Kai-Uwe, Sawhney, Monika, Schoettker, Ben, Shankar, Anoop, Shlipak, Michael, Silva, Diego Augusto Santos, Toyoshima, Hideaki, Ukwaja, Kingsley, Umesawa, Mitsumasa, Vollset, Stein Emil, Warnock, David G., Werdecker, Andrea, Yamagishi, Kazumasa, Yano, Yuichiro, Yonemoto, Naohiro, Zaki, Maysaa El Sayed, Naghavi, Mohsen, Forouzanfar, Mohammad H., Murray, Christopher J. L., Coresh, Josef, and Vos, Theo. “Global Cardiovascular and Renal Outcomes of Reduced GFR”. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 28.7 (2017): 2167-2179.

27 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Association of systolic blood pressure and pulse pressure with microalbuminuria in treatment-naïve hypertensive patients.
Xie N, Li X, Zhong Q, Zhou D, Cai A, Zhang Y, Zhou Y, Feng Y., Arch Med Sci 15(4), 2019
PMID: 31360177
Chronic kidney disease and kidney health care status: the healthy life in Suriname (HeliSur) study.
Nannan Panday R, Haan Y, Diemer F, Punwasi A, Rommy C, Heerenveen I, van Montfrans GA, Brewster LM., Intern Emerg Med 14(2), 2019
PMID: 30361850
Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project.
Runesson B, Qureshi AR, Xu H, Gasparini A, Lindholm B, Barany P, Elinder CG, Carrero JJ., PLoS One 14(1), 2019
PMID: 30650090
Risk profile, quality of life and care of patients with moderate and advanced CKD: The French CKD-REIN Cohort Study.
Stengel B, Metzger M, Combe C, Jacquelinet C, Briançon S, Ayav C, Fouque D, Laville M, Frimat L, Pascal C, Herpe YE, Morel P, Deleuze JF, Schanstra JP, Lange C, Legrand K, Speyer E, Liabeuf S, Robinson BM, Massy ZA., Nephrol Dial Transplant 34(2), 2019
PMID: 29635335
Identification of dicarbonyl and L-xylulose reductase as a therapeutic target in human chronic kidney disease.
Perco P, Ju W, Kerschbaum J, Leierer J, Menon R, Zhu C, Kretzler M, Mayer G, Rudnicki M, Nephrotic Syndrome Study Network (NEPTUNE)., JCI Insight 4(12), 2019
PMID: 31217356
Ghrelin-mediated pathway in Apolipoprotein-E deficient mice: a survival system.
Rezzani R, Franco C, Favero G, Rodella LF., Am J Transl Res 11(7), 2019
PMID: 31396333
High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome.
Miller-Hodges E, Anand A, Shah ASV, Chapman AR, Gallacher P, Lee KK, Farrah T, Halbesma N, Blackmur JP, Newby DE, Mills NL, Dhaun N., Circulation 137(5), 2018
PMID: 28978551
Pterostilbene protects against uraemia serum-induced endothelial cell damage via activation of Keap1/Nrf2/HO-1 signaling.
Chen ZW, Miu HF, Wang HP, Wu ZN, Wang WJ, Ling YJ, Xu XH, Sun HJ, Jiang X., Int Urol Nephrol 50(3), 2018
PMID: 29094331
Roxadustat in the treatment of anaemia in chronic kidney disease.
Del Vecchio L, Locatelli F., Expert Opin Investig Drugs 27(1), 2018
PMID: 29254377
Uric acid in chronic kidney disease: the quest for causality continues.
Zoccali C, Mallamaci F., Nephrol Dial Transplant 33(2), 2018
PMID: 29294051
Mild Albuminuria Is a Risk Factor for Faster GFR Decline in the Nondiabetic Population.
Melsom T, Solbu MD, Schei J, Stefansson VTN, Norvik JV, Jenssen TG, Wilsgaard T, Eriksen BO., Kidney Int Rep 3(4), 2018
PMID: 29989017
Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients.
Beberashvili I, Katkov A, Sinuani I, Azar A, Shapiro G, Feldman L, Gorelik O, Stav K, Efrati S., Am J Nephrol 47(4), 2018
PMID: 29694945
Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.
Luo S, Coresh J, Tin A, Rebholz CM, Chen TK, Hayek SS, Tracy M, Lipkowitz MS, Appel LJ, Levey AS, Inker LA, Reiser J, Grams ME., Clin J Am Soc Nephrol 13(7), 2018
PMID: 29903900
Predictors of chronic kidney disease and utility of risk prediction scores in HIV-positive individuals.
Woolnough EL, Hoy JF, Cheng AC, Walker RG, Chrysostomou A, Woolley I, Langham F, Moso MA, Weeraratne A, Trevillyan JM., AIDS 32(13), 2018
PMID: 29847332
Where Are You Going, Nephrology? Considerations on Models of Care in an Evolving Discipline.
Piccoli GB, Breuer C, Cabiddu G, Testa A, Jadeau C, Brunori G., J Clin Med 7(8), 2018
PMID: 30081442
Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study.
Reinecke H, Jürgensmeyer S, Engelbertz C, Gerss J, Kirchhof P, Breithardt G, Bauersachs R, Wanner C., BMJ Open 8(9), 2018
PMID: 30206088
Changes in the US Burden of Chronic Kidney Disease From 2002 to 2016: An Analysis of the Global Burden of Disease Study.
Bowe B, Xie Y, Li T, Mokdad AH, Xian H, Yan Y, Maddukuri G, Al-Aly Z., JAMA Netw Open 1(7), 2018
PMID: 30646390
Effects of Cardiovascular Risk Factors on Cardiac STAT3.
Pipicz M, Demján V, Sárközy M, Csont T., Int J Mol Sci 19(11), 2018
PMID: 30424579
Chronic Kidney Disease Severity Is Associated With Selective Expansion of a Distinctive Intermediate Monocyte Subpopulation.
Naicker SD, Cormican S, Griffin TP, Maretto S, Martin WP, Ferguson JP, Cotter D, Connaughton EP, Dennedy MC, Griffin MD., Front Immunol 9(), 2018
PMID: 30619252
Chronic kidney disease in low-income to middle-income countries: the case for increased screening.
George C, Mogueo A, Okpechi I, Echouffo-Tcheugui JB, Kengne AP., BMJ Glob Health 2(2), 2017
PMID: 29081996
Epidemiology: The global burden of reduced GFR: ESRD, CVD and mortality.
Sharma S, Sarnak MJ., Nat Rev Nephrol 13(8), 2017
PMID: 28626221
Chronic kidney disease and the global NCDs agenda.
Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V., BMJ Glob Health 2(2), 2017
PMID: 29225940
Chronic kidney disease and coronary artery calcification in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Suh-Chiou C, Moysés RM, Bittencourt MS, Bensenor IM, Lotufo PA., Clin Cardiol 40(12), 2017
PMID: 29243272

50 References

Daten bereitgestellt von Europe PubMed Central.

Prevalence of chronic kidney disease in the United States.
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS., JAMA 298(17), 2007
PMID: 17986697
Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient.
Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, Ura N, Kiyohara Y, Hirakata H, Moriyama T, Ando Y, Nitta K, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S., Clin. Exp. Nephrol. 11(2), 2007
PMID: 17593516
The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis.
Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, Patel U., Lancet Glob Health 2(3), 2014
PMID: 25102850
Prevalence of chronic kidney disease in two major Indian cities and projections for associated cardiovascular disease.
Anand S, Shivashankar R, Ali MK, Kondal D, Binukumar B, Montez-Rath ME, Ajay VS, Pradeepa R, Deepa M, Gupta R, Mohan V, Narayan KM, Tandon N, Chertow GM, Prabhakaran D; CARRS Investigators., Kidney Int. 88(1), 2015
PMID: 25786102
US Renal Data System 2012 Annual Data Report.
Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Ding S, Guo H, Kats A, Lamb K, Li S, Li S, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L., Am. J. Kidney Dis. 61(1 Suppl 1), 2013
PMID: 23253259
How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings?
Teerawattananon Y, Luz A, Pilasant S, Tangsathitkulchai S, Chootipongchaivat S, Tritasavit N, Yamabhai I, Tantivess S., Health Res Policy Syst 14(), 2016
PMID: 26988562
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.
van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium, van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey AS, de Jong PE, Gansevoort RT, Levey A, El-Nahas M, Eckardt KU, Kasiske BL, Ninomiya T, Chalmers J, Macmahon S, Tonelli M, Hemmelgarn B, Sacks F, Curhan G, Collins AJ, Li S, Chen SC, Hawaii Cohort KP, Lee BJ, Ishani A, Neaton J, Svendsen K, Mann JF, Yusuf S, Teo KK, Gao P, Nelson RG, Knowler WC, Bilo HJ, Joosten H, Kleefstra N, Groenier KH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T, van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey AS, de Jong PE, Gansevoort RT, Levey A, El-Nahas M, de Jong PE, Coresh J, Eckardt KU, Kasiske BL, Woodward M, Ninomiya T, Chalmers J, MacMahon S, Tonelli M, Hemmelgarn B, Tonelli M, Sacks F, Curhan G, Collins AJ, Li S, Chen SC, Lee BJ, Ishani A, Neaton J, Svendsen K, Mann JF, Yusuf S, Teo KK, Gao P, Nelson RG, Knowler WC, Mann JF, Yusuf S, Teo KK, Gao P, Bilo HJ, Joosten H, Kleefstra N, Groenier KH, Astor BC, Auguste P, Coresh J, Gansevoort RT, de Jong PE, Matsushita K, van der Velde M, Veldhuis K, Wang Y, Woodward M, Camarata L, Thomas B, Manley T., Kidney Int. 79(12), 2011
PMID: 21307840
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT, Levey AS, El-Nahas M, de Jong PE, Coresh J, Eckardt KU, Kasiske BL, Tonelli M, Hemmelgarn B, Coresh J, Astor BC, Matsushita K, Wang Y, Atkins RC, Polkinghorne KR, Chadban SJ, Shankar A, Klein R, Klein BE, Wang H, Wang F, Zhang L, Liu L, Shlipak M, Sarnak MJ, Katz R, Fried LP, Jafar T, Islam M, Hatcher J, Poulter N, Chaturvedi N, Rothenbacher D, Brenner H, Raum E, Koenig W, Fox CS, Hwang SJ, Meigs JB, Cirillo M, Hallan S, Lydersen S, Holmen J, Shlipak M, Sarnak MJ, Katz R, Fried LP, Roderick P, Nitsch D, Fletcher A, Bulpitt C, Astor BC, Coresh J, Ohkubo T, Metoki H, Nakayama M, Kikuya M, Imai Y, Gansevoort RT, de Jong PE, van der Velde M, Jassal SK, Barrett-Connor E, Bergstrom J, Warnock DG, Muntner P, Judd S, McClellan WM, Cushman M, Howard G, McClure LA, Jee SH, Kimm H, Yun JE, Wen CP, Wen SF, Tsao CK, Tsai MK, Arnlov J, Astor BC, Auguste P, Coresh J, Gansevoort RT, de Jong PE, Matsushita K, van der Velde M, Veldhuis K, Wang Y, Woodward M, Camarata L, Thomas B, Manley T., Lancet 375(9731), 2010
PMID: 20483451
CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race.
Hui X, Matsushita K, Sang Y, Ballew SH, Fulop T, Coresh J., Am. J. Kidney Dis. 62(4), 2013
PMID: 23769137
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals.
Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB., J. Am. Coll. Cardiol. 41(8), 2003
PMID: 12706933
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.
Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ., J. Am. Coll. Cardiol. 41(1), 2003
PMID: 12570944
The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.
Couser WG, Remuzzi G, Mendis S, Tonelli M., Kidney Int. 80(12), 2011
PMID: 21993585
Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
Boersma C, Gansevoort RT, Pechlivanoglou P, Visser ST, van Toly FF, de Jong-van den Berg LT, de Jong PE, Postma MJ; Prevention of Renal and Vascular End Stage Disease Study Group., Clin Ther 32(6), 2010
PMID: 20637965
Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease.
Barquera S, Pedroza-Tobias A, Medina C, Hernandez-Barrera L, Bibbins-Domingo K, Lozano R, Moran AE., Arch. Med. Res. 46(5), 2015
PMID: 26135634
The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study.
Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Flaxman A, Murray CJ, Naghavi M., Circulation 129(14), 2014
PMID: 24573351

AUTHOR UNKNOWN, 0
Ischemic Heart Disease Worldwide, 1990 to 2013: Estimates From the Global Burden of Disease Study 2013.
Shepard D, VanderZanden A, Moran A, Naghavi M, Murray C, Roth G., Circ Cardiovasc Qual Outcomes 8(4), 2015
PMID: 26152681
Worldwide access to treatment for end-stage kidney disease: a systematic review.
Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V., Lancet 385(9981), 2015
PMID: 25777665
Maintenance Dialysis throughout the World in Years 1990 and 2010.
Thomas B, Wulf S, Bikbov B, Perico N, Cortinovis M, Courville de Vaccaro K, Flaxman A, Peterson H, Delossantos A, Haring D, Mehrotra R, Himmelfarb J, Remuzzi G, Murray C, Naghavi M., J. Am. Soc. Nephrol. 26(11), 2015
PMID: 26209712
The fattening burden of type 2 diabetes on Mexicans: projections from early growth to adulthood.
Jimenez-Cruz A, Bacardi-Gascon M., Diabetes Care 27(5), 2004
PMID: 15111551
Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.
Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, Islam N, Bravo RF, Aleckovic-Halilovic M, Zou H, Zhang L, Gouda Z, Tchokhonelidze I, Abraham G, Mahdavi-Mazdeh M, Gallieni M, Codreanu I, Togtokh A, Sharma SK, Koirala P, Uprety S, Ulasi I, Remuzzi G., Lancet Glob Health 4(5), 2016
PMID: 27102194
Global nutrition transition and the pandemic of obesity in developing countries.
Popkin BM, Adair LS, Ng SW., Nutr. Rev. 70(1), 2012
PMID: 22221213
Childhood obesity and the metabolic syndrome in developing countries.
Gupta N, Shah P, Nayyar S, Misra A., Indian J Pediatr 80 Suppl 1(), 2013
PMID: 23334584

Vos T, Carter R, Barendregt J, Mihalopoulos C, Veerman JL, Magnus A, Cobiac L, Betram M, Wallace A., 0
Albuminuria: is it time to screen the general population?
Crews DC, Boulware LE, Gansevoort RT, Jaar BG., Adv Chronic Kidney Dis 18(4), 2011
PMID: 21782131
Meeting the World's Need for Maintenance Dialysis.
Wetmore JB, Collins AJ., J. Am. Soc. Nephrol. 26(11), 2015
PMID: 26209713
Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia.
Perico N, Plata R, Anabaya A, Codreanu I, Schieppati A, Ruggenenti P, Remuzzi G., Kidney Int. Suppl. (97), 2005
PMID: 16014107
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A., Lancet 387(10017), 2015
PMID: 26559744
Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes.
Kim SS, Kim JH, Kim IJ., Endocrinol Metab (Seoul) 31(2), 2016
PMID: 27246284
CKD of Uncertain Etiology: A Systematic Review.
Lunyera J, Mohottige D, Von Isenburg M, Jeuland M, Patel UD, Stanifer JW., Clin J Am Soc Nephrol 11(3), 2015
PMID: 26712810
Patient-centred innovation to ensure access to diabetes care in Cambodia: the case of MoPoTsyo.
van Olmen J, Eggermont N, van Pelt M, Hen H, de Man J, Schellevis F, Peters DH, Bigdeli M., J Pharm Policy Pract 9(), 2016
PMID: 26798483
An estimation of the prevalence and progression of chronic kidney disease in a rural diabetic cambodian population.
Thomas B, van Pelt M, Mehrotra R, Robinson-Cohen C, LoGerfo J., PLoS ONE 9(1), 2014
PMID: 24465909
Content, participants and outcomes of three diabetes care programmes in three low and middle income countries.
Van Olmen J, Marie KG, Christian D, Clovis KJ, Emery B, Maurits VP, Heang H, Kristien VA, Natalie E, Francois S, Guy K., Prim Care Diabetes 9(3), 2014
PMID: 25281167
Heat stress, dehydration, and kidney function in sugarcane cutters in El Salvador--A cross-shift study of workers at risk of Mesoamerican nephropathy.
Garcia-Trabanino R, Jarquin E, Wesseling C, Johnson RJ, Gonzalez-Quiroz M, Weiss I, Glaser J, Jose Vindell J, Stockfelt L, Roncal C, Harra T, Barregard L., Environ. Res. 142(), 2015
PMID: 26209462
CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy.
Correa-Rotter R, Wesseling C, Johnson RJ., Am. J. Kidney Dis. 63(3), 2014
PMID: 24412050
Chronic kidney disease: global dimension and perspectives.
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW., Lancet 382(9888), 2013
PMID: 23727169
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.
Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, Jafar T, Jassal SK, Landman GW, Muntner P, Roderick P, Sairenchi T, Schottker B, Shankar A, Shlipak M, Tonelli M, Townend J, van Zuilen A, Yamagishi K, Yamashita K, Gansevoort R, Sarnak M, Warnock DG, Woodward M, Arnlov J; CKD Prognosis Consortium, MacMahon S, Chalmers J, Arima H, Woodward M, Yatsuya H, Yamashita K, Toyoshima H, Tamakoshi K, Coresh J, Matsushita K, Atkins RC, Polkinghorne KR, Chadban S, Shankar A, Klein R, Klein BE, Lee KE, Tonelli M, Sacks FM, Curhan GC, Shlipak M, Sarnak MJ, Katz R, Iso H, Kitamura A, Imano H, Yamagishi K, Jafar TH, Islam M, Hatcher J, Poulter N, Chaturvedi N, Wheeler DC, Emberson J, Townend JN, Landray MJ, Brenner H, Rothenbacher D, Muller H, Schottker B, Fox CS, Hwang SJ, Meigs JB, Upadhyay A, Perkins R, Chang AR, Cirillo M, Hallan S, Aasarod K, Oien CM, Romundstad S, Iso H, Sairenchi T, Yamagishi K, Guallar E, Ryu S, Chang Y, Cho J, Shin H, Chodick G, Shalev V, Ash N, Shainberg B, Wetzels JF, Blankestijn PJ, van Zuilen AD, Sarnak MJ, Levey AS, Inker LA, Menon V, Shlipak M, Sarnak M, Katz R, Peralta C, Roderick P, Nitsch D, Fletcher A, Bulpitt C, Elley CR, Kenealy T, Moyes SA, Collins JF, Drury P, Ohkubo T, Metoki H, Nakayama M, Kikuya M, Imai Y, Gansevoort RT, Bakker SJ, Hillege HL, Heerspink HJ, Jassal SK, Bergstrom J, Ix JH, Barrett-Connor E, Warnock DG, Muntner P, Judd S, McClellan W, Jee SH, Kimm H, Mok Y, Tangri N, Sud M, Naimark D, Wen CP, Wen SF, Tsao CK, Tsai MK, Arnlov J, Lannfelt L, Larsson A, Bilo HJ, Kleefstra N, Groenier KH, Joosten H, Drion I, Coresh J, de Jong PE, Gansevoort RT, Iseki K, Levey AS, Matsushita K, Sarnak MJ, Stengel B, Warnock D, Woodward M, Ballew SH, Coresh J, Matsushita K, Woodward M., Lancet Diabetes Endocrinol 3(7), 2015
PMID: 26028594
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
Xie X, Liu Y, Perkovic V, Li X, Ninomiya T, Hou W, Zhao N, Liu L, Lv J, Zhang H, Wang H., Am. J. Kidney Dis. 67(5), 2015
PMID: 26597926
THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?
HILL AB., Proc. R. Soc. Med. 58(), 1965
PMID: 14283879
Cohort profile: the chronic kidney disease prognosis consortium.
Matsushita K, Ballew SH, Astor BC, Jong PE, Gansevoort RT, Hemmelgarn BR, Levey AS, Levin A, Wen CP, Woodward M, Coresh J; Chronic Kidney Disease Prognosis Consortium, Wright JT Jr, Appel L, Greene T, Astor BC, Chalmers J, MacMahon S, Woodward M, Arima H, Yatsuya H, Yamashita K, Toyoshima H, Tamakoshi K, Tonelli M, Hemmelgarn BR, Bello A, James M, Coresh J, Astor BC, Matsushita K, Sang Y, Atkins RC, Polkinghorne KR, Chadban S, Shankar A, Klein R, Klein BE, Lee KE, Wang H, Wang F, Zhang L, Zuo L, Levin A, Djurdjev O, Tonelli M, Sacks FM, Curhan GC, Shlipak M, Peralta C, Katz R, Fried L, Iso H, Kitamura A, Ohira T, Yamagishi K, Jafar TH, Islam M, Hatcher J, Poulter N, Chaturvedi N, Landray MJ, Emberson JR, Townend JN, Wheeler DC, Rothenbacher D, Brenner H, Muller H, Schottker B, Fox CS, Hwang SJ, Meigs JB, Perkins RM, Fluck N, Clark LE, Prescott GJ, Marks A, Black C, Cirillo M, Hallan S, Aasarod K, Oien CM, Radtke M, Irie F, Iso H, Sairenchi T, Yamagishi K, Smith DH, Weiss JW, Johnson ES, Thorp ML, Collins AJ, Vassalotti JA, Li S, Chen SC, Lee BJ, Wetzels JF, Blankestijn PJ, van Zuilen AD, Sarnak M, Levey AS, Inker L, Menon V, Shlipak M, Sarnak M, Peralta C, Katz R, Kramer HJ, de Boer IH, Kronenberg F, Kollerits B, Ritz E, Roderick P, Nitsch D, Fletcher A, Bulpitt C, Ishani A, Neaton JD, Froissart M, Stengel B, Metzger M, Haymann JP, Houillier P, Flamant M, Astor BC, Coresh J, Matsushita K, Metoki H, Nakayama M, Kikuya M, Imai Y, Iseki K, Nelson RG, Knowler WC, Gansevoort RT, de Jong PE, Mahmoodi BK, Bakker SJ, Hillege HL, van der Harst P, Jassal SK, Barrett-Connor E, Bergstrom J, Heerspink HJ, Brenner BE, de Zeeuw D, Warnock DG, Muntner P, Judd S, McClellan W, Jee SH, Kimm H, Jo J, Mok Y, Choi E, Rossing P, Parving HH, Tangri N, Naimark D, Wen CP, Wen SF, Tsao CK, Tsai MK, Arnlov J, Lannfelt L, Larsson A, Bilo HJ, Joosten H, Kleefstra N, Groenier KH, Drion I, Astor BC, Coresh J, Gansevoort RT, Hemmelgarn BR, de Jong PE, Levey AS, Levin A, Matsushita K, Wen CP, Woodward M, Ballew SH, Coresh J, Grams M, Mahmoodi BK, Matsushita K, Sang Y, Woodward M, Camarata L, Hui X, Seltzer J, Winegrad H., Int J Epidemiol 42(6), 2012
PMID: 23243116

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 28408440
PubMed | Europe PMC

Suchen in

Google Scholar